share_log

莱美药业:关于控股子公司纳米炭铁混悬注射液获得II期临床试验伦理批件的公告

Laimei Pharmaceutical: Announcement on the holding subsidiary obtaining ethical approval for phase II clinical trials of nano-carbon iron suspension injections

SZSI ·  Aug 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more